Trade

with

OxiGene Inc
(NASDAQ: OXGN)
AdChoices
2.15
+0.18
+9.14%
After Hours :
2.15
0.00
0.00%

Open

2.05

Previous Close

1.97

Volume (Avg)

1.59M (408.54k)

Day's Range

2.01-2.23

52Wk Range

1.75-5.40

Market Cap.

44.52M

Dividend Rate ( Yield )

-

Beta

2.07

Shares Outstanding

20.71M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 95.00k

    • Net Income

    • -8.28M

    • Market Cap.

    • 44.52M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -14,336.84

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.07

    • Forward P/E

    • -2.56

    • Price/Sales

    • 188.68

    • Price/Book Value

    • 1.28

    • Price/Cash flow

    • -1.77

      • EBITDA

      • -8.17M

      • Return on Capital %

      • -60.33

      • Return on Equity %

      • -64.38

      • Return on Assets %

      • -60.33

      • Book Value/Share

      • 1.69

      • Shares Outstanding

      • 20.71M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 6.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.84

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 51.25

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -11,896.84

            • 39.38

            • Net Profit Margin

            • -14,336.84

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 18.86

              • 2.92

              • Quick Ratio

              • 18.62

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.06

              • 2.21

              • Book Value/Share

              • 1.69

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.24

                • 217.39

                • P/E Ratio 5-Year High

                • -250.18

                • 634.30

                • P/E Ratio 5-Year Low

                • -1.07

                • 124.82

                • Price/Sales Ratio

                • 178.57

                • 9.52

                • Price/Book Value

                • 1.20

                • 8.61

                • Price/Cash Flow Ratio

                • -1.77

                • 50.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -64.38

                    (-1,986.40)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -60.33

                    (-156.50)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -64.38

                    (-1,986.40)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • -

                  • 1.48

                  • Asset Turnover

                  • 0.00

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -8.28M
                  Operating Margin
                  -8,715.79
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -1.77
                  Ownership

                  Institutional Ownership

                  22.41%

                  Top 10 Institutions

                  45.63%

                  Mutual Fund Ownership

                  3.26%

                  Float

                  98.60%

                  5% / Insider Ownership

                  10.44%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Bridgeway Ultra Small Company Fund

                  •  

                    203,600

                  • 159.03

                  • 0.98

                  • Vanguard Total Stock Mkt Idx

                  •  

                    191,662

                  • 0.00

                  • 0.93

                  • Vanguard Extended Market Index Fund

                  •  

                    158,429

                  • 14.32

                  • 0.77

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    55,832

                  • 0.00

                  • 0.27

                  • iShares Micro-Cap

                  •  

                    55,534

                  • 0.00

                  • 0.25

                  • FlexShares Mstar US Mkt Factors Tilt ETF

                  •  

                    5,848

                  • 0.00

                  • 0.03

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    3,718

                  • 0.00

                  • 0.02

                  • Vanguard US Equity Index

                  •  

                    1,284

                  • 0.00

                  • 0.01

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    561

                  • 0.00

                  • 0.00

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Perceptive Advisors LLC

                  •  

                    379,200

                  • -24.16%

                  • 1.83

                  • Bridgeway Capital Management, Inc

                  •  

                    203,600

                  • +159.03%

                  • 0.98

                  • Vanguard Group, Inc.

                  •  

                    202,027

                  • +2.88%

                  • 0.98

                  • GRT Capital Partners LLC

                  •  

                    69,800

                  • 0.00%

                  • 0.34

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  OxiGene, Inc., is a biopharmaceutical company. It is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer.

                  Key People

                  Dr. David Chaplin,PhD

                  CEO/Director/President

                  Frederick W. Driscoll

                  Chairman of the Board/Director

                  Ms. Barbara Riching

                  CFO/Chief Accounting Officer/Vice President

                  Dr. Gerald McMahon,PhD

                  Director

                  Dr. William D. Schwieterman,M.D.

                  Director

                  • OxiGene Inc

                  • 701 Gateway Boulevard

                  • South San Francisco, CA 94080

                  • USA.Map

                  • Phone: +1 650 635-7000

                  • Fax: +1 650 635-7001

                  • oxigene.com

                  Incorporated

                  1988

                  Employees

                  10

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: